Show simple item record

dc.contributor.authorAxford, Nick
dc.contributor.authorBerry, V
dc.contributor.authorLloyd, J
dc.contributor.authorHobbs, T
dc.contributor.authorWyatt, K
dc.date.accessioned2020-07-10T10:34:17Z
dc.date.issued2020-08-04
dc.identifier.issn1389-4986
dc.identifier.issn1573-6695
dc.identifier.urihttp://hdl.handle.net/10026.1/15991
dc.description.abstract

<jats:title>Abstract</jats:title><jats:p>There can be a tendency for investigators to disregard or explain away null or negative results in prevention science trials. Examples include not publicizing findings, conducting spurious subgroup analyses, or attributing the outcome post hoc to real or perceived weaknesses in trial design or intervention implementation. This is unhelpful for several reasons, not least that it skews the evidence base, contributes to research “waste”, undermines respect for science, and stifles creativity in intervention development. In this paper, we identify possible policy and practice responses when interventions have null (ineffective) or negative (harmful) results, and argue that these are influenced by: the<jats:italic>intervention</jats:italic>itself (e.g., stage of gestation, perceived importance);<jats:italic>trial design</jats:italic>,<jats:italic>conduct</jats:italic>,<jats:italic>and results</jats:italic>(e.g., pattern of null/negative effects, internal and external validity);<jats:italic>context</jats:italic>(e.g., wider evidence base, state of policy); and<jats:italic>individual perspectives and interests</jats:italic>(e.g., stake in the intervention). We advance several strategies to promote more informative null or negative effect trials and enable learning from such results, focusing on changes to culture, process, intervention design, trial design, and environment.</jats:p>

dc.format.extent751-763
dc.format.mediumPrint
dc.languageen
dc.language.isoen
dc.publisherSpringer Verlag
dc.subjectRandomized controlled trial
dc.subjectNull effect
dc.subjectNegative effect
dc.subjectEvaluation
dc.titlePromoting learning from null or negative results in prevention science trials
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000555380700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue5
plymouth.volume23
plymouth.publication-statusPublished
plymouth.journalPrevention Science
dc.identifier.doi10.1007/s11121-020-01140-4
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/FoH - Community and Primary Care
plymouth.organisational-group/Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited States
dcterms.dateAccepted2020-07-09
dc.rights.embargodate2020-8-7
dc.identifier.eissn1573-6695
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1007/s11121-020-01140-4
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2020-08-04
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV